Recombinant multi-species CRYZ protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CRYZ protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Crystallins are separated into two classes: taxon-specific, or enzyme, and ubiquitous. The latter class constitutes the major proteins of vertebrate eye lens and maintains the transparency and refractive index of the lens. The former class is also called phylogenetically-restricted crystallins. This gene encodes a taxon-specific crystallin protein which has NADPH-dependent quinone reductase activity distinct from other known quinone reductases. It lacks alcohol dehydrogenase activity although by similarity it is considered a member of the zinc-containing alcohol dehydrogenase family. Unlike other mammalian species, in humans, lens expression is low. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. One pseudogene is known to exist. [provided by RefSeq, Sep 2008]
The Alternative Names of target: CRYZ,Cryz,NADPH:quinone reductase,Quinone oxidoreductase,Sez9,Zeta-crystallin

Target products collectionGo to CRYZ products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T83284-Ag-1/ GM-Tg-hg-T83284-Ag-2 Human CRYZ protein Human
GM-Tg-rg-T83284-Ag-1/ GM-Tg-rg-T83284-Ag-2 Rat CRYZ protein Rat
GM-Tg-mg-T83284-Ag-1/ GM-Tg-mg-T83284-Ag-2 Mouse CRYZ protein Mouse
GM-Tg-cynog-T83284-Ag-1/ GM-Tg-cynog-T83284-Ag-2 Cynomolgus/Rhesus macaque CRYZ protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T83284-Ag-1/ GM-Tg-felg-T83284-Ag-2 Feline CRYZ protein Feline
GM-Tg-cang-T83284-Ag-1/ GM-Tg-cang-T83284-Ag-2 Canine CRYZ protein Canine
GM-Tg-bovg-T83284-Ag-1/ GM-Tg-bovg-T83284-Ag-2 Bovine CRYZ protein Bovine
GM-Tg-equg-T83284-Ag-1/ GM-Tg-equg-T83284-Ag-2 Equine CRYZ protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T83284-Ag-1/ GM-Tg-hg-T83284-Ag-2; GM-Tg-rg-T83284-Ag-1/ GM-Tg-rg-T83284-Ag-2;
GM-Tg-mg-T83284-Ag-1/ GM-Tg-mg-T83284-Ag-2; GM-Tg-cynog-T83284-Ag-1/ GM-Tg-cynog-T83284-Ag-2;
GM-Tg-felg-T83284-Ag-1/ GM-Tg-felg-T83284-Ag-2; GM-Tg-cang-T83284-Ag-1/ GM-Tg-cang-T83284-Ag-2;
GM-Tg-bovg-T83284-Ag-1/ GM-Tg-bovg-T83284-Ag-2; GM-Tg-equg-T83284-Ag-1/ GM-Tg-equg-T83284-Ag-2
Products Name CRYZ protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CRYZ
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CRYZ protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.